Grantham, Mayo, Van Otterloo & Co (GMO)’s NutriSystem, Inc. NTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-11,700
Closed -$450K 622
2018
Q2
$450K Sell
11,700
-1,900
-14% -$63K ﹤0.01% 477
2018
Q1
$367K Buy
13,600
+2,000
+17% +$79.6K ﹤0.01% 505
2017
Q4
$610K Sell
11,600
-32,300
-74% -$1.7M ﹤0.01% 442
2017
Q3
$2.45M Sell
43,900
-6,400
-13% -$347K 0.01% 306
2017
Q2
$2.62M Buy
50,300
+45,700
+993% +$2.37M 0.01% 302
2017
Q1
$255K Buy
+4,600
New +$190K ﹤0.01% 461

Other funds holding NTRI

Grantham, Mayo, Van Otterloo & Co (GMO)'s NTRI Position: Q3 2018 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of NutriSystem, Inc. (NTRI) in Q3 2018, closing a stake of 11,700 shares — an estimated $450K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NTRI in Q1 2017 and held it in 6 quarters. The position peaked at $2.62M in Q2 2017. 219 funds tracked by Wall St. Rank hold NTRI as of Q3 2018.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining NutriSystem, Inc. position as of Q3 2018 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 11,700 NutriSystem, Inc. shares in Q3 2018, an estimated $450K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NutriSystem, Inc. in Q1 2017 and held it in 6 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s NutriSystem, Inc. position peaked at $2.62M in Q2 2017.
  • 219 funds tracked by Wall St. Rank held NutriSystem, Inc. as of Q3 2018.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2018, filed 14 Nov 2018.